Skip to content
Screener

Opko Health OPK Q1 2026 earnings

Reported April 28, 2026 · After market close

Revenue$124.2MMiss by $6.3M
EPS-$0.07In line
Revenue estimate$130.5M
EPS estimate-$0.07

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$136.6M
EPS estimate-$0.07

Financials

Q1 2026

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$865.34M-22.4%
Enterprise value$918.12M-21.5%
P/S1.5×-0.1×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0×0.0×
Current ratio3.6×+1.1×

Segments

By product

See full
Intellectual Property And Other$14.0M+13.8%
Transfer Of Intellectual Property And Other$14.0M+13.6%
Rayaldee$12.8M-2.3%

FAQ

When did Opko Health report Q1 2026 earnings?
Opko Health (OPK) reported Q1 2026 earnings on April 28, 2026 after market close.
What were Opko Health's Q1 2026 revenue and EPS?
Opko Health reported revenue of $124.2M and eps of $-0.07 for Q1 2026.
Did Opko Health beat estimates in Q1 2026?
Revenue missed the consensus estimate of $130.5M by $6.3M. EPS beat the consensus estimate of $-0.07 by $0.00.
How did Opko Health's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 17.2% from $150.0M a year earlier and eps grew 30.0% from $-0.10.
Where can I find Opko Health's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-186939) and the 10-Q periodic report (0001193125-26-187007) directly on SEC EDGAR. The filing index links above go to sec.gov.